Clinical trial
SINGULAIR (R) as Complementary Therapy to Fixed Association Regimen (0476-363)
NCT00445107 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00445107 |
|---|---|
| Title | SINGULAIR (R) as Complementary Therapy to Fixed Association Regimen (0476-363) |
| Official title | An Open Label, Observational Study to Assess The Efficacy, Safety and Tolerability of Added Singulair in Persistent Asthma Patients With or Without Allergic Rhinitis and Long Acting B-Agonist |
| Acronym | STAR |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | MK0476, montelukast sodium / Duration of Treatment: 8 Weeks |
| Enrollment | 198 |
| Start date | Nov 1, 2005 |
| Primary completion | May 1, 2006 |
| Completion | May 17, 2006 |
| First posted | Mar 8, 2007 |
| Last update posted | Aug 15, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: